{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:07:01Z","timestamp":1785434821382,"version":"3.56.0"},"reference-count":47,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["R01GM120523"],"award-info":[{"award-number":["R01GM120523"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["R01HL163854"],"award-info":[{"award-number":["R01HL163854"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["R35GM131770"],"award-info":[{"award-number":["R35GM131770"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["HL133786"],"award-info":[{"award-number":["HL133786"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec id=\"abs1\">\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Two risk variants in the apolipoprotein L1 gene (\n                      <jats:italic>APOL1<\/jats:italic>\n                      ) have been associated with increased susceptibility to sepsis in Black patients. However, it remains unclear whether\n                      <jats:italic>APOL1<\/jats:italic>\n                      high-risk genotypes are associated with occurrence of either sepsis or sepsis-related phenotypes in patients hospitalized with infections, independent of their association with pre-existing severe renal disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A retrospective cohort study of 2242 Black patients hospitalized with infections. We assessed whether carriage of\n                      <jats:italic>APOL1<\/jats:italic>\n                      high-risk genotypes was associated with the risk of sepsis and sepsis-related phenotypes in patients hospitalized with infections. The primary outcome was sepsis; secondary outcomes were short-term mortality, and organ failure related to sepsis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of 2242 Black patients hospitalized with infections, 565 developed sepsis. Patients with high-risk\n                      <jats:italic>APOL1<\/jats:italic>\n                      genotypes had a significantly increased risk of sepsis (odds ratio [OR]=1.29 [95% CI, 1.00\u20131.67; p=0.047]); however, this association was not significant after adjustment for pre-existing severe renal disease (OR = 1.14 [95% CI, 0.88\u20131.48; p=0.33]), nor after exclusion of those patients with pre-existing severe renal disease (OR = 0.99 [95% CI, 0.70\u20131.39; p=0.95]).\n                      <jats:italic>APOL1<\/jats:italic>\n                      high-risk genotypes were significantly associated with the renal dysfunction component of the Sepsis-3 criteria (OR = 1.64 [95% CI, 1.21\u20132.22; p=0.001]), but not with other sepsis-related organ dysfunction or short-term mortality. The association between high-risk\n                      <jats:italic>APOL1<\/jats:italic>\n                      genotypes and sepsis-related renal dysfunction was markedly attenuated by adjusting for pre-existing severe renal disease (OR = 1.36 [95% CI, 1.00\u20131.86; p=0.05]) and was nullified after exclusion of patients with pre-existing severe renal disease (OR = 1.16 [95% CI, 0.74\u20131.81; p=0.52]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs4\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      <jats:italic>APOL1<\/jats:italic>\n                      high-risk genotypes were associated with an increased risk of sepsis; however, this increased risk was attributable predominantly to pre-existing severe renal disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs5\">\n                    <jats:title>Funding:<\/jats:title>\n                    <jats:p>This study was supported by R01GM120523 (QF), R01HL163854 (QF), R35GM131770 (CMS), HL133786 (WQW), and Vanderbilt Faculty Research Scholar Fund (QF). The dataset(s) used for the analyses described were obtained from Vanderbilt University Medical Center\u2019s BioVU which is supported by institutional funding, the 1S10RR025141-01 instrumentation award, and by the CTSA grant UL1TR0004from NCATS\/NIH. Additional funding provided by the NIH through grants P50GM115305 and U19HL065962. The authors wish to acknowledge the expert technical support of the VANTAGE and VANGARD core facilities, supported in part by the Vanderbilt-Ingram Cancer Center (P30 CA068485) and Vanderbilt Vision Center (P30 EY08126). The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7554\/elife.88538","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T09:21:48Z","timestamp":1687944108000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.88538","source":"Crossref","is-referenced-by-count":4,"title":["Association between APOL1 risk variants and the occurrence of sepsis in Black patients hospitalized with infections: a retrospective cohort study"],"prefix":"10.7554","volume":"12","author":[{"given":"Lan","family":"Jiang","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center","place":["Nashville, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Liu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biomedical Informatics, Vanderbilt University Medical Center","place":["Nashville, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Oeser","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center","place":["Nashville, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ihegword","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center","place":["Nashville, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3404-3802","authenticated-orcid":true,"given":"Alyson L","family":"Dickson","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center","place":["Nashville, United States"]},{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center","place":["Nashville, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3143-5915","authenticated-orcid":true,"given":"Laura L","family":"Daniel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dgjyy92","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Rheumatology, Department of Medicine, University of Miami","place":["Miami, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana M","family":"Hung","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01c9rqr26","id-type":"ROR","asserted-by":"publisher"}],"name":"Tennessee Valley Healthcare System, Nashville Campus","place":["Nashville, United States"]},{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Nephrology & Hypertension, Vanderbilt University Medical Center","place":["Nashville, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J","family":"Cox","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Vanderbilt Genetics Institute, Department of Medicine, Vanderbilt University Medical Center","place":["Nashville, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia P","family":"Chung","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dgjyy92","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Rheumatology, Department of Medicine, University of Miami","place":["Miami, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Qi","family":"Wei","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biomedical Informatics, Vanderbilt University Medical Center","place":["Nashville, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Michael","family":"Stein","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center","place":["Nashville, United States"]},{"id":[{"id":"https:\/\/ror.org\/02vm5rt34","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pharmacology, Vanderbilt University","place":["Nashville, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6213-793X","authenticated-orcid":true,"given":"Qiping","family":"Feng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center","place":["Nashville, United States"]},{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Vanderbilt Genetics Institute, Department of Medicine, Vanderbilt University Medical Center","place":["Nashville, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.chest.2022.01.016","article-title":"Prevalence and outcomes of previously healthy adults among patients hospitalized with community-onset sepsis","volume":"162","author":"Alrawashdeh","year":"2022","journal-title":"Chest"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Critical Care Medicine"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.kint.2020.01.027","article-title":"Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways","volume":"97","author":"Bajaj","year":"2020","journal-title":"Kidney International"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"Journal of Chronic Diseases"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/jgs.16797","article-title":"Race, APOL1 risk variants, and clinical outcomes among older adults: the ARIC study","volume":"69","author":"Chen","year":"2021","journal-title":"Journal of the American Geriatrics Society"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41581-022-00538-3","article-title":"The evolving story of apolipoprotein L1 nephropathy: the end of the beginning","volume":"18","author":"Daneshpajouhnejad","year":"2022","journal-title":"Nature Reviews. Nephrology"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","article-title":"Next-generation genotype imputation service and methods","volume":"48","author":"Das","year":"2016","journal-title":"Nature Genetics"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/ng.2795","article-title":"Common variants associated with plasma triglycerides and risk for coronary artery disease","volume":"45","author":"Do","year":"2013","journal-title":"Nature Genetics"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/ki.2008.346","article-title":"Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome","volume":"74","author":"Doi","year":"2008","journal-title":"Kidney International"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1473-3099(17)30117-2","article-title":"Application of the Third International Consensus Definitions for Sepsis (Sepsis-3) Classification: a retrospective population-based cohort study","volume":"17","author":"Donnelly","year":"2017","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/GIM.0b013e3181efe2df","article-title":"Assessing the accuracy of observer-reported ancestry in a biorepository linked to electronic medical records","volume":"12","author":"Dumitrescu","year":"2010","journal-title":"Genetics in Medicine"},{"key":"bib13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.11130","article-title":"A Genetic approach to the Association between PCSK9 and Sepsis","volume":"2","author":"Feng","year":"2019","journal-title":"JAMA Network Open"},{"key":"bib14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.7223","article-title":"Association between low-density lipoprotein cholesterol levels and risk for sepsis among patients admitted to the hospital with infection","volume":"2","author":"Feng","year":"2019","journal-title":"JAMA Network Open"},{"key":"bib15","article-title":"Apol1_Sepsis","volume-title":"Software Heritage","author":"FengLabVUMC","year":"2023","unstructured":"FengLabVUMC. 2023. Apol1_Sepsis. Software Heritage. swh:1:rev:6d9205176a7670f55c72c7c5ae7df8fa9096848e. https:\/\/archive.softwareheritage.org\/swh:1:dir:7c1ce3d3bfeaa5510407dbcfa3ca928b345e4c53;origin=https:\/\/github.com\/FengLabVUMC\/APOL1_Sepsis;visit=swh:1:snp:31247f6c8061024e4f8efc32f2e35b5294d1aa9c;anchor=swh:1:rev:6d9205176a7670f55c72c7c5ae7df8fa9096848e."},{"key":"bib16","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans","volume":"24","author":"Foster","year":"2013","journal-title":"Journal of the American Society of Nephrology"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1053\/j.ajkd.2018.06.020","article-title":"APOL1-Associated Nephropathy: a key contributor to racial disparities in CKD","volume":"72","author":"Freedman","year":"2018","journal-title":"American Journal of Kidney Diseases"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-physiol-021119-034345","article-title":"APOL1 and Kidney Disease: from Genetics to Biology","volume":"82","author":"Friedman","year":"2020","journal-title":"Annual Review of Physiology"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/MNH.0000000000000816","article-title":"Treatment potential in APOL1-associated nephropathy","volume":"31","author":"Friedman","year":"2022","journal-title":"Current Opinion in Nephrology and Hypertension"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1001\/jamainternmed.2021.8538","article-title":"APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants with African Ancestry Hospitalized With COVID-19 from the Million Veteran Program","volume":"182","author":"Hung","year":"2022","journal-title":"JAMA Internal Medicine"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"Journal of the American Society of Nephrology"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/ndt\/gfu391","article-title":"APOL1 nephropathy: from gene to mechanisms of kidney injury","volume":"31","author":"Kruzel-Davila","year":"2016","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","article-title":"APOL1 kidney risk alleles: population genetics and disease associations","volume":"21","author":"Limou","year":"2014","journal-title":"Advances in Chronic Kidney Disease"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/ki.2015.109","article-title":"APOL1 toxin, innate immunity, and kidney injury","volume":"88","author":"Limou","year":"2015","journal-title":"Kidney International"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/ki.2012.263","article-title":"Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans","volume":"83","author":"Lipkowitz","year":"2013","journal-title":"Kidney International"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/cts.13462","article-title":"The relationship between high density lipoprotein cholesterol and sepsis: A clinical and genetic approach","volume":"16","author":"Liu","year":"2023","journal-title":"Clinical and Translational Science"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"The New England Journal of Medicine"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1001\/jama.2010.851","article-title":"Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis","volume":"303","author":"Mayr","year":"2010","journal-title":"JAMA"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/ng.3643","article-title":"A reference panel of 64,976 haplotypes for genotype imputation","volume":"48","author":"McCarthy","year":"2016","journal-title":"Nature Genetics"},{"key":"bib31","article-title":"Charlson Comorbidity Index (CCI)","author":"MDCalc","year":"2019","unstructured":"MDCalc. 2019. Charlson Comorbidity Index (CCI). https:\/\/www.mdcalc.com\/charlson-comorbidity-index-cci [Accessed May 7, 2019]."},{"key":"bib32","article-title":"Charlson\/Deyo Score","author":"National Cancer Data Base - Data Dictionary PUF","year":"2013","unstructured":"National Cancer Data Base - Data Dictionary PUF. 2013. Charlson\/Deyo Score. http:\/\/ncdbpuf2013.facs.org\/content\/charlsondeyo-comorbidity-index [Accessed May 6, 2020]."},{"key":"bib33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney International"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.semnephrol.2017.07.007","article-title":"The Cell Biology of APOL1","volume":"37","author":"O\u2019Toole","year":"2017","journal-title":"Seminars in Nephrology"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1097\/CCM.0000000000005017","article-title":"Current trends in sepsis-related mortality in the united states","volume":"49","author":"Prest","year":"2021","journal-title":"Critical Care Medicine"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Medical Care"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jama.2017.13836","article-title":"Incidence and trends of Sepsis in US Hospitals using Clinical vs Claims Data, 2009-2014","volume":"318","author":"Rhee","year":"2017","journal-title":"JAMA"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/j.1523-1755.2000.00337.x","article-title":"Mortality caused by sepsis in patients with end-stage renal disease compared with the general population","volume":"58","author":"Sarnak","year":"2000","journal-title":"Kidney International"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis: For the third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Human Genetics"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000330673","article-title":"Chronic kidney disease and risk of death from infection","volume":"34","author":"Wang","year":"2011","journal-title":"American Journal of Nephrology"},{"key":"bib42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175508","article-title":"Evaluating phecodes, clinical classification software, and ICD-9-CM codes for phenome-wide association studies in the electronic health record","volume":"12","author":"Wei","year":"2017","journal-title":"PLOS ONE"},{"key":"bib43","doi-asserted-by":"publisher","DOI":"10.2196\/14325","article-title":"Mapping ICD-10 and ICD-10-CM Codes to Phecodes: workflow development and initial evaluation","volume":"7","author":"Wu","year":"2019","journal-title":"JMIR Medical Informatics"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.immuni.2021.10.004","article-title":"APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis","volume":"54","author":"Wu","year":"2021","journal-title":"Immunity"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1093\/hmg\/ddab024","article-title":"Kidney disease and APOL1","volume":"30","author":"Yusuf","year":"2021","journal-title":"Human Molecular Genetics"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jmoldx.2015.11.003","article-title":"Analytical validation of a personalized medicine APOL1 genotyping assay for nondiabetic chronic kidney disease risk assessment","volume":"18","author":"Zhang","year":"2016","journal-title":"The Journal of Molecular Diagnostics"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1093\/bioinformatics\/bts606","article-title":"A high-performance computing toolset for relatedness and principal component analysis of SNP data","volume":"28","author":"Zheng","year":"2012","journal-title":"Bioinformatics"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/88538\/elife-88538-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/88538\/elife-88538-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/88538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T09:25:46Z","timestamp":1698312346000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/88538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":47,"alternative-id":["10.7554\/eLife.88538"],"URL":"https:\/\/doi.org\/10.7554\/elife.88538","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.7554\/eLife.88538.2","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2023.01.27.23284540","asserted-by":"subject"}],"is-same-as":[{"id-type":"doi","id":"10.7554\/eLife.88538.3","asserted-by":"subject"}],"is-version-of":[{"id-type":"doi","id":"10.7554\/eLife.88538.1","asserted-by":"subject"},{"id-type":"doi","id":"10.7554\/eLife.88538.2","asserted-by":"subject"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"RP88538"}}